ReviewBiomedicines2023

Amivantamab-Vmjw: A Novel Treatment for Patients with NSCLC Harboring EGFR Exon 20 Insertion Mutation after Progression on Platinum-Based Chemotherapy.

Vishal Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.